HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

6th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 20-22, 2025 | Orlando, Florida, USA

GAB 2025

Combining repetitive transcranial stimulation with transcranial direct current stimulation for psychiatric conditions: A scoping review

Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2025 - Trevyna William
University of Manitoba, Canada
Title : Combining repetitive transcranial stimulation with transcranial direct current stimulation for psychiatric conditions: A scoping review

Abstract:

Background: Repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) have been thoroughly explored in the treatment of various psychiatric disorders and neuropsychiatric symptoms. There is an increasing number of studies exploring the combination of both modalities to treat mental illness. In this scoping review, we summarize all existing studies that have combined rTMS and tDCS to remedy psychiatric disorders and symptoms.

Methods: We comprehensively searched four databases (Embase, PsycINFO, MEDLINE and CENTRAL) in addition to grey literature. Studies necessarily consisted of at least one patient who received both rTMS and tDCS for a psychiatric condition or symptom. Multiple validated tools were used for appraisal of quality and risk of bias.

Results: Fourteen studies were reviewed, which related to unipolar depression (five), bipolar disorder (two), obsessive-compulsive disorder (two), chronic insomnia (two), Alzheimer’s Disease (one), stress (one) and depressive and anxiety symptoms (one). Three Randomized controlled trials (RCTs) on unipolar depression generally showcased superior depressive symptom improvement, response and remission rates compared to rTMS or tDCS alone. One RCT on chronic insomnia noted greater improvements in sleep quality/efficiency and depressive symptoms compared to monotherapy. The frequency of side effects with combined treatment was comparable to monotherapy. The reviewed studies noted no significant adverse events.

Conclusion: The current body of evidence highlights a likely superior efficacy of combining rTMS and tDCS for unipolar depression compared to either modality alone. Future studies can extend combined treatment to other psychiatric conditions using protocols that have shown previous success in monotherapy studies.

Biography:

Trevyna, a 4th-year medical student from the University of Manitoba, Canada. Her undergraduate degree is in psychology, and she plan to pursue a career in psychiatry. Her current research interests include interventional psychiatry, brain imaging, and neurodevelopmental disorders. The project she presenting highlights the literature on combining rTMS and tDCS in treating mental illness. Based on the limited but promising results from the scoping review, we hope to build on this research in the future by performing local pilot studies for patients with depression

Watsapp